Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sensus Healthcare (SRTS) Short-term Investments (2016 - 2020)

Historic Short-term Investments for Sensus Healthcare (SRTS) over the last 5 years, with Q2 2020 value amounting to $459295.0.

  • Sensus Healthcare's Short-term Investments fell 9148.18% to $459295.0 in Q2 2020 from the same period last year, while for Jun 2020 it was $459295.0, marking a year-over-year decrease of 9148.18%. This contributed to the annual value of $7.4 million for FY2019, which is 15549.52% up from last year.
  • As of Q2 2020, Sensus Healthcare's Short-term Investments stood at $459295.0, which was down 9148.18% from $3.7 million recorded in Q1 2020.
  • In the past 5 years, Sensus Healthcare's Short-term Investments registered a high of $8.0 million during Q3 2019, and its lowest value of $459295.0 during Q2 2020.
  • Moreover, its 5-year median value for Short-term Investments was $4.7 million (2019), whereas its average is $4.5 million.
  • In the last 5 years, Sensus Healthcare's Short-term Investments skyrocketed by 16182.31% in 2018 and then plummeted by 9148.18% in 2020.
  • Over the past 5 years, Sensus Healthcare's Short-term Investments (Quarter) stood at $6.5 million in 2016, then tumbled by 82.91% to $1.1 million in 2017, then surged by 161.82% to $2.9 million in 2018, then surged by 155.5% to $7.4 million in 2019, then plummeted by 93.78% to $459295.0 in 2020.
  • Its Short-term Investments was $459295.0 in Q2 2020, compared to $3.7 million in Q1 2020 and $7.4 million in Q4 2019.